In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study

被引：0
|
作者：
F Bonifazi
G Bandini
M Stanzani
F Palandri
B Giannini
M Arpinati
G Rosti
M Baccarani
机构：
[1] University of Bologna,Institute of Hematology ‘L. and A. Seràgnoli’
[2] S Orsola-Malpighi Hospital,undefined
来源：
Bone Marrow Transplantation | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1025 / 1026
页数：1
相关论文
共 50 条
  • [1] In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML:: results from a prospective phase II study
    Bonifazi, F
    Bandini, G
    Stanzani, M
    Palandri, F
    Giannini, B
    Arpinati, M
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 1025 - 1026
  • [2] Pre-transplant low dose ATG as prophilylaxis for chronic GvHD after peripheral blood stem cell myeloablative sibling transplants in AML: A single center experience
    Specchia, G.
    Pastore, D.
    Mestice, A.
    Carluccio, P.
    Perrone, T.
    Gaudio, F.
    Mazzone, A. M.
    Mongelli, P.
    Manduzio, P.
    Leo, M.
    Liso, V.
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 382 - 382
  • [3] Pre-transplant low dose ATG as prophlylaxis for chronic GvHD after peripheral blood stem cell myeloablative sibling transplants in AML: a single-centre experience
    Pastore, D.
    Mestice, A.
    Carluccio, P.
    Perrone, T.
    Gaudio, F.
    Leo, M.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S119 - S120
  • [4] Low-dose rabbit ATG prevents GvHD in sibling allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia
    Bonifazi, F
    Bandini, G
    Falcioni, S
    Palandri, F
    Stanzani, M
    Amabile, M
    Martinelli, G
    Motta, MR
    Rizzi, S
    El-Cheick, J
    Giannini, B
    Farese, O
    Rovito, M
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S311 - S311
  • [5] T-cell depletion effects of low-dose antithymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation
    Shiratori, Souichi
    Kosugi-Kanaya, Mizuha
    Hayase, Eiko
    Okada, Kohei
    Goto, Hideki
    Sugita, Junichi
    Onozawa, Masahiro
    Nakagawa, Masao
    Kahata, Kaoru
    Hashimoto, Daigo
    Endo, Tomoyuki
    Kondo, Takeshi
    Teshima, Takanori
    TRANSPLANT IMMUNOLOGY, 2018, 46 : 21 - 22
  • [6] Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    Wolschke, C.
    Zabelina, T.
    Ayuk, F.
    Alchalby, H.
    Berger, J.
    Klyuchnikov, E.
    Pein, U-M
    Schumacher, S.
    Amtsfeld, G.
    Adjalle, R.
    Wortmann, F.
    Lellek, H.
    Randenborgh, A.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 (01) : 126 - 130
  • [7] Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    C Wolschke
    T Zabelina
    F Ayuk
    H Alchalby
    J Berger
    E Klyuchnikov
    U-M Pein
    S Schumacher
    G Amtsfeld
    R Adjallé
    F Wortmann
    H Lellek
    A Randenborgh
    A Zander
    N Kröger
    Bone Marrow Transplantation, 2014, 49 : 126 - 130
  • [8] Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas:: first results of a prospective multicenter study
    Reimer, P
    Schertlin, T
    Rüdiger, T
    Geissinger, E
    Roth, S
    Kunzmann, V
    Weissinger, F
    Nerl, C
    Schmitz, N
    Müller-Hermelink, HK
    Wilhelm, M
    HEMATOLOGY JOURNAL, 2004, 5 (04) : 304 - 311
  • [9] In vivo T-cell depletion with anti-lymphocyte globulin (ATG) in HLA-identical sibling peripheral blood stem cell transplantation results in effective prevention of severe and chronic graft-versus-host disease without increasing risk of relapse
    Wolschke, C.
    Zabelina, T.
    Ayuk, F.
    Alchalby, H.
    Berger, J.
    Klyuchnikov, E.
    Schumacher, S.
    von Pein, U.
    Amtsfeld, G.
    Adjalle, R.
    Worthmann, F.
    Lellek, H.
    van Randenborgh, A.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S226 - S226
  • [10] In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease.
    Dodero, A
    Milani, R
    Carrabba, M
    Rizzo, E
    Milanesi, M
    Longoni, P
    Montefusco, V
    Farina, L
    Lucesole, M
    Leoni, P
    Olivieri, A
    Corradini, P
    BLOOD, 2003, 102 (11) : 449B - 450B
12345